Trial · NCT03788967
Trial comparisons14
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 14 of 14
Download this page as JSON| Comparison | Source |
|---|---|
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Clinical Cure at TOC Days in the ME-TOC Populations | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Clinical Cure at EOT Days the Clinically Evaluable (CE-EOT) Populations | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Clinical Cure at EOT in the ME-EOT Populations | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: By-Patient Microbiological Eradication at EOT in the ME-EOT Populations | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Clinical Cure at TOC in the CE-TOC Populations | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: By-Patient Microbiological Eradication at TOC in the ME-TOC Population | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Number of Participants With Treatment Emergent Adverse Events (TEAEs) in The Safety Population | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Sustained Clinical Cure at LFU in the CE-LFU Populations | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: By-Patient Sustained Microbiological Eradication at LFU Days in the ME-LFU Populations | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Sustained Clinical Cure at LFU in the ME-LFU Population | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Overall Response (Combined Clinical Cure and Microbiological Eradication) at Test-of-Cure (TOC) in Micro Intent-to-Treat Population | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: deaths from any cause | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: Overall Response (Combined Clinical Cure Plus Microbiological Eradication) At Test-Of-Cure (TOC) In The Microbiologically Evaluable (ME) - TOC Population | Trial comparisons |
| TBPM-PI-HBr 600 mg vs Ertapenem 1 g: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03788967/comparisons